All relevant data are within the paper and its Supporting Information files and available on PeptideAtlas under the identifier PASS00903.

Introduction {#sec004}
============

*Treponema pallium* ssp. *pallidum*, henceforth referred to as *T*. *pallidum*, is the causative agent of syphilis, a multistage chronic disease with an estimated 8 million new cases per year \[[@pntd.0004988.ref001]\]. Recent outbreaks of syphilis infection among certain populations such as men who have sex with men (MSM) \[[@pntd.0004988.ref002]\], together with continuing substantial perinatal morbidity and mortality attributed to congenital syphilis infections \[[@pntd.0004988.ref003]\], highlight the need for improved diagnostics and vaccine development.

*T*. *pallidum* is an obligate microaerophilic bacterial pathogen \[[@pntd.0004988.ref004]--[@pntd.0004988.ref006]\] that is aptly suited to invading mammalian tissue by the use of endoflagella that produce undulations in travelling planar waves \[[@pntd.0004988.ref007]\], thereby driving its characteristic corkscrew-like movement \[[@pntd.0004988.ref008]\]. The membrane of *T*. *pallidum* lacks lipopolysaccharide (LPS) and the loosely associated fragile outer membrane contains a low amount of proteins \[[@pntd.0004988.ref008]--[@pntd.0004988.ref011]\]. Many biomedical experimental approaches such as genetic manipulation have been hampered by its lack of *in vitro* cultivability \[[@pntd.0004988.ref012]\]. Despite these limitations, numerous studies using *T*. *pallidum* harvested from the experimental rabbit model have increased our basic biological understanding of this unique organism, including the description of the genome \[[@pntd.0004988.ref013],[@pntd.0004988.ref014]\], transcriptome \[[@pntd.0004988.ref015]\] and proteome \[[@pntd.0004988.ref016],[@pntd.0004988.ref017]\].

The *T*. *pallidum* Nichols strain genome was sequenced for the first time in the late 1990's \[[@pntd.0004988.ref013]\], revealing only 1041 predicted open reading frames (ORFs) on a 1.14 Mb circular chromosome, making it one of the smallest human pathogen genomes. Resequencing of the Nichols strain \[[@pntd.0004988.ref014]\] identified 102 errors that were predicted to affect protein-coding genes and reduced the number of ORFs to 1039, 968 of which are predicted to be protein coding. Similar to other obligate pathogens such as *Mycoplasma pneumoniae* \[[@pntd.0004988.ref018]\], *T*. *pallidum* is predicted to have lost many non-essential genes though genome reduction. This theory is supported by extensive genome-wide transcriptional analyses \[[@pntd.0004988.ref015]\], which revealed the uniform expression of almost all *T*. *pallidum* genes during experimental rabbit infection. Consequently, *T*. *pallidum* has severely limited metabolic and biosynthetic capabilities, rendering it highly dependent on the host milieu and nutrients \[[@pntd.0004988.ref019]\].

The predicted proteins found within *T*. *pallidum* range in size from 3,235 to 172,869 Da with an average size of 37,771 Da \[[@pntd.0004988.ref013],[@pntd.0004988.ref020]\]. Early studies on *T*. *pallidum* polypeptides, including pre-MS analysis gel-based techniques and the use of recombinant DNA technology has been extensively reviewed by Norris *et al*. \[[@pntd.0004988.ref017]\] and Schouls \[[@pntd.0004988.ref021]\]. A large scale *T*. *pallidum* recombinant protein study included the construction of a bacterial artificial chromosome (BAC) library containing 901 of the 1039 *T*. *pallidum* predicted proteins for expression in *Escherichia coli* \[[@pntd.0004988.ref022],[@pntd.0004988.ref023]\]; many of the expressed proteins were reactive with sera from syphilis-infected rabbits and/or humans \[[@pntd.0004988.ref024],[@pntd.0004988.ref025]\] at different stages of infection as determined by serological reactivity studies. Subsequently, McGill *et al*. conducted a *T*. *pallidum* proteome investigation on *in vivo* expressed *T*. *pallidum* using gel-based approaches complemented with MALDI-TOF Mass Spectrometry (MS) and peptide mass fingerprinting \[[@pntd.0004988.ref016]\]. A total of 88 polypeptides were identified and the immunoreactive potential of select proteins was characterized. Numerous bioinformatic approaches have been used to characterize *T*. *pallidum* proteins, including lipoprotein characterization \[[@pntd.0004988.ref026]\], the determination of potential outer membrane proteins \[[@pntd.0004988.ref027]\] and the re-annotation of *T*. *pallidum* strain SS14 hypothetical proteins \[[@pntd.0004988.ref028]\]. However, despite rigorous analyses and major advances in genome sequencing, approximately 30% of *T*. *pallidum* proteins still have no known orthologues and at present cannot be assigned a biological function \[[@pntd.0004988.ref013]\]. This 'unknown' category of proteins may represent an arsenal of genes encoding virulence factors specific for *T*. *pallidum* \[[@pntd.0004988.ref020]\].

Progress has been made on understanding virulence and persistence strategies of this unique pathogen. Genetic sequence diversity is primarily localized in six hot spots \[[@pntd.0004988.ref029]\] in *T*. *pallidum* ssp. *pallidum* and *T*. *pallidum* ssp. *pertenue* (the causative agents of Yaws), including regions encoding members of the paralogous *tpr* gene family consisting of 12 genes categorized into subfamilies I (*tpr*C, D, F and I), II (*tpr*E, G and J) and III (*tpr*A, B, H, K and L). The Tpr proteins contribute to antigenic variation that aids in immune evasion \[[@pntd.0004988.ref030]\]. Nonreciprocal gene conversion occurs between donor sites and several variable regions (V1--7) in *tprK* \[[@pntd.0004988.ref031]\] and these variable regions in the encoded protein are targets of the host humoral response during infection \[[@pntd.0004988.ref032]--[@pntd.0004988.ref035]\]. Host immune pressure is capable of selecting against certain TprK sequence epitopes \[[@pntd.0004988.ref036]\] and TprK sequence variability can help evade the host immune response \[[@pntd.0004988.ref035]\] during infection. Recombinant protein studies have confirmed surface exposure, bipartite architecture and porin function related to the outer membrane proteins Tpr C/D \[[@pntd.0004988.ref037]\] and TprI \[[@pntd.0004988.ref038]\]. Moreover, *T*. *pallidum* lipoproteins, of which Tp47 is the most widely studied \[[@pntd.0004988.ref039]--[@pntd.0004988.ref042]\], play an important role in immune system activation and evasion as reviewed by Kelesidis *et al*. \[[@pntd.0004988.ref043]\].

With the recent evolution of robust highly sensitive tandem MS instrumentation, the comprehensive description of bacterial proteomes, also referred to as shotgun proteomics (reviewed by Semanjski *et al*. \[[@pntd.0004988.ref044]\]), is achievable. Many current state-of-the-art proteomic studies have approached 80% coverage of the predicted expressed proteome \[[@pntd.0004988.ref045],[@pntd.0004988.ref046]\]. The study of pathogens expressed *in vivo* is of particular interest since this would be the closest approximation of human pathophysiological conditions. For example, previous studies on the *Mycoplasma tuberculosis* proteome from guinea pig infected lungs during early and chronic stages of disease \[[@pntd.0004988.ref047]\] have provided valuable insights into pathogen protein expression. However, interference of host proteins present in large excess can hinder MS detection of low abundance pathogen proteins. Thus, several strategies have been used to overcome issues of sample complexity to enrich bacteria cells, such as the use of density gradient centrifugation \[[@pntd.0004988.ref016]\].

Using highly sensitive non-gel based complementary proteomic techniques, we sought to further elucidate the global proteome of *T*. *pallidum* in order to gain insights into the fundamental physiological state of *T*. *pallidum* during rabbit infection. Three biological replicates of *in vivo* cultured *T*. *pallidum* were subjected to multidimensional chromatographic separation and tandem MS/MS analysis whereby 557 *T*. *pallidum* proteins were identified at a high level of confidence, representing 54% of the predicted proteome. This is the first description of 499 *T*. *pallidum* proteins expressed *in vivo*, of which 106 were annotated as uncharacterized/hypothetical proteins. Detected proteins were comprehensively analysed to predict cellular localization and function. This unique 'snapshot' view of the *T*. *pallidum* proteome during infection extends our understanding of *T*. *pallidum* pathogenesis and forms the basis for further proteome investigations.

Methods {#sec005}
=======

Rabbit inoculation and *T*. *pallidum* purification using Percoll density gradient centrifugation {#sec006}
-------------------------------------------------------------------------------------------------

Three biological samples, hereafter referred to as samples TPA-A, TPB-B and TPC-C, originated from three New Zealand White rabbits that were inoculated intra-testicularily with *T*. *pallidum* DAL-1 strain bacteria according to established methods \[[@pntd.0004988.ref048]\]. Inoculations originated from two different bacterial stocks of DAL-1 strain bacteria, whereby sample TPB-B and TPC-C originated from the same stock. When peak orchitis was reached, on average 11--14 days post-inoculation, rabbits were sacrificed using T61 administration according to the manufacturer\'s instructions and the bacteria was extracted from the testes and purified using Percoll density gradient centrifugation as previously described \[[@pntd.0004988.ref049]\]. Briefly, collected organisms were separated from host cellular gross debris by low-speed centrifugation at 34 800 g for 30 minutes followed by gradient separation via ultra-centrifugation at 100 000 g for 1 hour. Bacteria were quantified using darkfield microscopy and a counting chamber. For sample TPA-A, approximately 10^8−9^ treponemes were re-suspended and stored in 1 mL NaCl solution and frozen at -80°C. For samples TPB-B and TPC-C, approximately 10^8−9^ treponemes were re-suspended in 1 mL phosphate buffered saline (PBS) (HiMedia Laboratories, Mumbai, India) and frozen at -80°C. Two samples, TPA-A and TPB-B, were subjected to an extra thaw cycle before protein extraction due to inadvertent thawing during sample shipment. Each rabbit was tested serologically to rule out a naturally occurring infection with *T*. *paraluiscuniculi*.

Ethics statement {#sec007}
----------------

The treponemal DAL-1 strain was propagated in rabbits at the Veterinary Research Institute in Brno, Czech Republic. The handling of animals in the study was performed in accordance with the current Czech legislation (Animal Protection and Welfare Act No. 246/1992 Coll. of the Government of the Czech Republic). These specific experiments were approved by the Ethics Committee of the Veterinary Research Institute (Permit Number 20--2014).

*T*. *pallidum* protein sample preparation {#sec008}
------------------------------------------

Cell lysis of the purified *T*. *pallidum* extract was performed by conducting three consecutive freeze-thaw cycles, followed by ultrasonication on ice with an amplitude of 50% and a pulser frequency of 2 seconds for 2 minutes (Sonics, Vibra cell; Newton USA). Protein concentration was determined by loading a small fraction of the lysed sample on a high performance liquid chromatographic (HPLC) reversed phase C4 system that was calibrated using a serial dilution of a protein standard mixture. Protein concentrations were determined based on the area under the curve (AUC at 214 nm). Approximately 400--500 μg of protein was extracted from each biological replicate; a large proportion of this amount was host protein in the form of albumin. Samples were acetone precipitated by adding 6 volumes of LC-MS grade acetone (Biosolve, Valkenswaard, Netherlands) and incubated overnight at -20°C. In all cases, lo-bind Eppendorf tubes (Eppendorf, Hamburg, Germany) were used to ensure high recovery rates of proteins/peptides.

Protein enzymatic digestion {#sec009}
---------------------------

Following protein precipitation, protein samples were re-suspended in 50 mM Tris-HCl/6 M urea/5 mM DTT/10% beta-mercaptoethanol (25 μL/100 μg protein) at pH 8.7. For the denaturation and reduction process all samples were incubated at 65°C during 1 hour. Subsequently, proteins in all fractions were diluted in 50 mM Tris-HCl/ 1 mM CaCl~2~ (75 μL/100 μg protein) and alkylated by adding 200 mM iodoacetamide (10 μL/100 μg protein) during 1 hour at room temperature. Proteomics-grade modified trypsin (Promega, Madison, Wisconsin, United States) was added at a 30:1 protein-to-enzyme ratio. After incubation at 37°C for 18 hour the digestion was stopped by freezing the samples.

Peptide separation by reversed phase C18 at high pH (1^st^ dimension) {#sec010}
---------------------------------------------------------------------

After tryptic digestion, peptides were separated in a first dimension based on hydrophobicity at high pH by using a reversed phase C18 column (X!Select, CSH, RP-C18, 2.1 x 150 mm, 3.5 μm, Waters) connected to a Waters Alliance e2695 HPLC bio-system and a Waters 996 PDA detector (Waters Corporation, Milford, MA, USA). Solvent A contains 200 mM ammonium formate at pH 10, while solvent C contains 100% water and solvent D 100% acetonitrile (ACN) (LC-MS grade, Biosolve, Valkenswaard, Netherlands). During the chromatographic run, an ACN gradient was performed, while continuously 10% of solvent A was added to become an overall pH of 10 during the entire run. The following gradient was used at a constant flow rate of 200 μL/min: 5% to 15% D over the first 5 min, 15% to 40% D over 80 min, 40% to 90% D over 8 min, 5 min 90% D, and 90% to 5% D over 2 min. In total, 30 fractions were collected starting from 10 to 100 min with an interval of 3 min/fraction. The peptide concentration of the different fractions was determined based on the area under the curve (AUC at 214 nm). Fractions were pooled in a concatenated way (e.g. fractions 1, 11 and 21) to obtain optimal orthogonality, yielding in total 10 fractions for further analysis. Collected fractions were lyophilized and re-suspended in RP mobile phase (97% water, 3% ACN, 0.1% FA).

Peptide separation by micro-capillary reversed phase C18 (2^nd^ dimension) {#sec011}
--------------------------------------------------------------------------

Peptide fractions were separated in a second dimension using an Agilent 1100 series micro-capillary HPLC system (Agilent Technologies, Waldbronn, Germany). For each fraction 15 μg of peptides was injected on a Zorbax 300SB-C18 guard column (0.3 mm x 5 mm; particle size 3.5 μm; Agilent Technologies) serially connected with a Zorbax 300SB-C18 analytical RP column (0.3 mm x 150 mm; particle size 3.5 μm; Agilent Technologies). Samples were online desalted by loading the peptides on the guard column before the ACN gradient was started. Solvent A contained 0.1% formic acid (FA) in water while solvent B contained 0.1% FA in 90% ACN /10% water. Following ACN gradient was performed using the capillary pump with a constant flow rate at 6 μL/min: 5% to 60% B in 56.7 min, ramp to 90% B over 3.3 min persistent 90% B for 5 min, 85% B for 5 min and back to equilibrating conditions of 3% B. Starting from minute 5 until minute 51.7 of the chromatographic run, 350 spots (800 nl/spot) for each fraction were spotted on an Opti-TOF MALDI-target (28 columns x 25 rows; 8 sec interval; 700 spots; 2 runs per target) (Applied Biosystems, Inc.). Afterwards, each spot was covered with matrix (2 mg/ml α-cyano-4-hydroxycinnamic acid in 70% ACN; internal calibrant: 93 pmol/ml human \[Glu^1^\]-fibrinopeptide B) using an external syringe pump with a 4 second interval (800 nl matrix/spot) at a flow rate of 12 μL/min.

MALDI-TOF/TOF MS/MS analysis {#sec012}
----------------------------

Spotted fractions were offline analysed using a MALDI ABi4800 proteomics analyser (Applied Biosystems). MALDI-TOF MS-analysis (reflectron mode; laser intensity: 3400; 25 x 20 laser shots per spot; mass-range 800--3000 Da) was performed first, after which precursors were selected with a signal-to-noise (S/N) ratio above or equal to 100. \[Glu^1^\]-fibrinopeptide B (m/z 1570.667) was used as internal standard to calibrate MS-spectra. MALDI-TOF/TOF MS/MS-analysis was performed on the selected MS precursors. A maximum of 50 unique precursors per spot were selected for fragmentation, starting from the precursors with the lowest S/N- ratio. These precursors were ionized (laser intensity: 4300; 25 x 20 laser shots per spot) and fragmented in a collision cell (CID, 1 kV collision energy).

MALDI-TOF/TOF MS/MS spectral data analysis {#sec013}
------------------------------------------

Spectra from each sample were extracted by Peak Explorer and screened against a *T*. *pallidum* database UniProt proteomes IDs [UP000014259](http://www.uniprot.org/proteomes/UP000014259) and [UP000000811](http://www.uniprot.org/proteomes/UP000000811) using the MASCOT search engine (Matrix Science; version 2.1.03) based on the digestion enzyme trypsin. We chose to screen against the Nichols strain database since the DAL-1 strain proteome is not well annotated and the genetic differences between the strains are minimal and described \[[@pntd.0004988.ref050]\]. The latter database is generally used as the treponemal reference database while the former is a more recent version. Carbamidomethylation of cysteines was listed as fixed modification, while oxidation of methionine was set as a variable modification. A maximum of two missed cleavages of trypsin was tolerated. Mass tolerance was set to 200 ppm for the precursors and 0.20 Da for the fragment ions. The MudPIT scoring algorithm of MASCOT was used. Scaffold Q+ (version Scaffold 4.0.5, Proteome Software Inc., Portland, OR) was used to validate MS/MS-based peptide and protein identifications. Because the *T*. *pallidum* proteome contains several small proteins with just one or a few detectable tryptic peptides, protein identifications based on one unique peptide were only allowed if they fulfilled certain stringent conditions; these criteria were comprised by the peptide prophet algorithm that was performed by Scaffold Q+. Protein identifications were accepted if they could be established at greater than 95.0% probability according to the protein prophet algorithm.

Protein abundances were estimated based on the spectral counts (SC) of each identified protein by calculating the normalized spectral abundance factor (NSAF) as previously described \[[@pntd.0004988.ref051]\]. In short, this approach includes a normalisation step based on (1) the observable peptides (OP) and (2) on the total number of identified peptides. The NSAF values reflecting an average of the biological and technical runs of each detected proteins are provided in [S3 Table](#pntd.0004988.s003){ref-type="supplementary-material"}. Pearson's correlation test and Mann Whitney test were calculated to compare the cDNA/DNA signal data to the NSAF protein abundance data. A P-value of \< 0.05 was considered statistically significant. All analyses were performed in Stata 12 (StataCorp LP, College Station, TX, USA).

In order to determine whether the identification methodology was stringent enough, the false discovery rate (FDR) was defined on protein level by using a concatenated database consisting of the target spectral database and a shuffled database. Calculation of FDR was performed as follows: 2x false positive identifications / (false positive identifications + true positive identifications) \[[@pntd.0004988.ref052]\]. For all samples, the FDR on protein level had to be less than 5%. Spectra were also screened against the mammalian Swissprot database containing human (*Homo sapiens*) and rabbit (*Oryctolagus cuniculus*) proteomes for spectra verification to prevent assignment of peptides with a conserved amino acid sequence.

Orbitrap Velos LTQ MS/MS analysis {#sec014}
---------------------------------

### Nano reverse phase liquid chromatography and mass spectrometry {#sec015}

The peptide mixtures were separated in the second dimension by reverse phase chromatography on an Eksigent nano-UPLC system using an Acclaim C18 PepMap100 nano-Trap column (200 μm x 20 mm, 5 μm particle size) connected to an Acclaim C18 analytical column (75 μm x 150 mm, 3 μm particle size) (Thermo Scientific, San Jose, CA). Peptide fractions were dissolved in mobile phase A, containing 2% ACN and 0,1% formic acid and spiked with 20 fmol \[Glu^1^\]-fibrinopeptide B. A linear gradient of mobile phase B (0,1% FA in 98% ACN) in mobile phase A (0,1% FA in 2% ACN) from 2 to 45% B in 35 min followed by a steep increase to 95% mobile phase B in 2 min was used at a flow rate of 350 nl/min. The nano-LC was coupled online with the mass spectrometer using a PicoTip Emitter (New objective, Woburn, MA) coupled to a nanospray ion source.

The LTQ Orbitrap Velos (Thermo Scientific, San Jose, CA) was set up in a data dependent MS/MS mode where a full scan spectrum (350--5000 m/z, resolution 60000) was followed by a maximum of ten CID tandem mass spectra (100 to 2000 m/z). Peptide ions were selected as the twenty most intense peaks of the MS scan. Collision induced dissociation (CID) scans were acquired in the LTQ ion trap part of the mass spectrometer. The normalized collision energy used was 35% in CID. A dynamic exclusion list of 45 sec for data dependent acquisition was applied.

Orbitrap Velos LTQ MS/MS spectral data analysis {#sec016}
-----------------------------------------------

Spectra from each sample were extracted by Proteome discoverer software (Thermo Scientific, San Jose, CA) and screened against a *T*. *pallidum* database (UniProt ID proteomes IDs [UP000014259](http://www.uniprot.org/proteomes/UP000014259) and [UP000000811](http://www.uniprot.org/proteomes/UP000000811)) using the MASCOT search engine (Matrix Science; version 2.1.03) based on the digestion enzyme trypsin. Carbamidomethylation of cysteines was listed as fixed modification, while methionine oxidation was set as variable modification. A maximum of two missed cleavages of trypsin was tolerated. Mass tolerance was set to 10 ppm for the precursors and 0.8 Da for the fragment ions. The MudPIT scoring algorithm of MASCOT was used. Further protein identification, quantification and validation procedures were conducted as mentioned above for the MALDI-TOF/TOF analysis. All Orbitrap LTQ mass spectrometric data are available at PeptideAtlas \[[@pntd.0004988.ref053]\]. The identifier is PASS00903.

Identification of known and predicted *T*. *pallidum* membrane proteins {#sec017}
-----------------------------------------------------------------------

Initially, all potential membrane proteins were identified from the 557 *T*. *pallidum* proteins detected by mass spectrometry by: (1) analyzing annotated functions (and subcellular localizations, if available) from all published *T*. *pallidum* ssp. *pallidum* genome sequences (<http://www.ncbi.nlm.nih.gov/genome/?term=treponema+pallidum%5Borgn%5D>), (2) identification of lipoproteins based on previous bioinformatic analyses performed by Setubal *et al*. \[[@pntd.0004988.ref026]\], (3) identification of rare outer membrane proteins based on previous bioinformatic analyses performed by Cox *et al*. \[[@pntd.0004988.ref027]\], and (4) by additional review of experimental findings in the scientific literature. Next, all potential membrane proteins (and proteins annotated as 'uncharacterized', 'hypothetical' or 'conserved hypothetical') were analyzed using 5 bioinformatic prediction tools. The SignalP 4.1 server (<http://www.cbs.dtu.dk/services/SignalP/>) \[[@pntd.0004988.ref054]\] and the LipoP 1.0 server (<http://www.cbs.dtu.dk/services/LipoP/>) \[[@pntd.0004988.ref055]\] were used to predict the presence and location of potential signal peptide cleavage sites and lipoprotein signal peptides, respectively. PSORTb version 3.0.2 (<http://www.psort.org/psortb/>) \[[@pntd.0004988.ref056]\] was used to predict protein subcellular localization. TMHMM server version 2.0 (<http://www.cbs.dtu.dk/services/TMHMM-2.0/>) \[[@pntd.0004988.ref057]\] and PRED-TMBB (<http://bioinformatics.biol.uoa.gr/PRED-TMBB/>) \[[@pntd.0004988.ref058]\] were used for predicting the presence and location of transmembrane alpha-helices and beta strands, respectively. Proteins with unclear subcellular localization predictions using the above bioinformatic pipeline were further analyzed using the following eight prediction tools. CELLO version 2.5 (<http://cello.life.nctu.edu.tw/>) \[[@pntd.0004988.ref059]\] was used to predict subcellular localization. Philius (<http://www.yeastrc.org/philius/pages/philius/runPhilius.jsp>) \[[@pntd.0004988.ref060]\], Phobius (<http://phobius.sbc.su.se/>) \[[@pntd.0004988.ref061]\], Octopus/Spoctopus (<http://octopus.cbr.su.se/index.php>) \[[@pntd.0004988.ref062]\], HMMTOP version 2.0 (<http://www.enzim.hu/hmmtop/html/submit.html>) \[[@pntd.0004988.ref063]\], and TMpred (<http://www.ch.embnet.org/software/TMPRED_form.html>) were used for the prediction of transmembrane alpha-helices BOMP (<http://services.cbu.uib.no/tools/bomp>) \[[@pntd.0004988.ref064]\] and TMBETADISC-RBF (<http://rbf.bioinfo.tw/~sachen/OMPpredict/TMBETADISC-RBF.php>) \[[@pntd.0004988.ref065]\] were used for the prediction of beta-barrel outer membrane proteins.

Assignment of orthologous functional categories and cellular localization {#sec018}
-------------------------------------------------------------------------

The eggNOG version 4 database (retrieved 21/04/15) was used to assign COG and NOG categories to all genomes. First all proteins per sample were compared to the eggNOG database using USEARCH version 7.0.959 with an e-value of 1e-30 and a bit-score cut-off of 70% of the top hit to ensure only close matches were retrieved and reduce the likelihood of spurious annotations. An eggNOG membership is assigned to each protein if 70% of the UBLAST hits belong to the same eggNOG member. Distinctions are then made between proteins with no UBLAST hit to any eggNOG sequence (no_hit) and over 70% of hits to a member that is not assigned an eggNOG code (none). Annotations are also clustered at the 25 higher COG functional category levels as per the eggNOG assignments. Classification of proteins according to their cellular location was achieved using data extraction from online databases (Swissprot) and the methods as outlined for the membrane localized proteins.

Results and Discussion {#sec019}
======================

Mass spectrometry analysis {#sec020}
--------------------------

In short, from the three biological replicates, a total of 6033 *T*. *pallidum* peptides were detected corresponding to 557 proteins and 54% of the total predicted proteome ([S1 Table](#pntd.0004988.s001){ref-type="supplementary-material"}). Proteins ranged in size from 6--173 kDa with a pI range of 4.15 to 12.05. Acquired spectra were screened against two Nichols strain UniProt proteomes whereby three extra proteins (TP0248, TP0651 and TP0922) were uncovered compared to when solely screened against the Nichols reference UniProt proteome (ID: UP000000811) \[[@pntd.0004988.ref013]\]. In the resequenced proteome (ID: UP000014259) \[[@pntd.0004988.ref014]\] three of these proteins were below the 150bp annotation limit. We found 57/102 proteins containing previously reported sequencing errors \[[@pntd.0004988.ref014]\] compared to the original genome analysis \[[@pntd.0004988.ref013]\], including two genes with an authentic frameshift, 14 reannotated gene fusions and 5 novel ORFs reannotated in the new proteome ([S2 table](#pntd.0004988.s002){ref-type="supplementary-material"}).

Pertaining to the individual samples, 394/398 (TPA-A), 279/321 (TPB-B) and 217/247 (TPC-C) proteins were uniquely identified by MALDI-TOF/TOF and ESI- MS/MS analysis, respectively, of which 106 (MALDI-TOF/TOF) and 119 (ESI- MS/MS) proteins were present in all three biological samples ([Fig 1A/1B](#pntd.0004988.g001){ref-type="fig"}). Only 31 proteins were found with less than 2 peptide identifications in one biological and one technical run ([S3 Table](#pntd.0004988.s003){ref-type="supplementary-material"}). For the individual MS analyses (MALDI- TOF/TOF *versus* ESI- LTQ Orbitrap MS/MS detection), 514 proteins were detected by both methods ([Fig 2C](#pntd.0004988.g002){ref-type="fig"}). Only one and 42 additional proteins were exclusively identified by MALDI- TOF/TOF MS/MS analysis and ESI-MS/MS analysis, respectively ([Fig 2C](#pntd.0004988.g002){ref-type="fig"}) indicating that we are possibly approaching the upper limit of the detectable *T*. *pallidum* proteome and that the non-detected proteins are 1) not expressed, or 2) are expressed at a very low level. All *T*. *pallidum* designated spectra were rescreened against human and rabbit UniProt protein databases and no overlap was found.

![Venn Diagrams depicting the total number of unique *T*. *pallidum* proteins identified per rabbit biological replicate (N = 3) analyzed by (A) Matrix-assisted laser desorption/ionization time of flight and (B) Electrospray Ionization LTQ- Orbitrap Velos MS/MS.\
All spectra were screened against the UniProt databases (ID: UP000000811 & UP000014259), with a peptide and protein identification confidence interval of 95%. There was considerable overlap between the complementary MS analytical methods whereby an additional 42 treponemal proteins were found in the Orbitrap analysis as depicted in diagram (C).](pntd.0004988.g001){#pntd.0004988.g001}

![Bar Diagram depicting the distribution of the detected and undetected *T*. *pallidum* proteins distributed in 19 COG functional categories.\
Blue bars represent MS detected proteins in this study. Red bars represent all predicted proteins in the *T*. *pallidum* proteome. The functional category was automatically determined for genes that could be placed in Clusters of Orthologous Groups (COGs). For genes with more than one COG category both categories were used.](pntd.0004988.g002){#pntd.0004988.g002}

A previous proteomics study of *in vivo* rabbit expressed *T*. *pallidum* Nichols strain bacteria \[[@pntd.0004988.ref016]\] detected 88 proteins using MALDI-TOF MS with peptide mass fingerprinting. We detected 58 of these proteins, therefore, to date 58% of the whole *T*. *pallidum* predicted proteome has been detected using MS methods. We failed to detect 30 of these previously identified proteins as outlined in [Table 1](#pntd.0004988.t001){ref-type="table"}. The protein detection differences between the studies could be attributed to different experimental methods, for example gel-based *versus* liquid chromatographic separation, which may favor the detection of proteins with certain physiochemical characteristics. Although the differences on the genomic level between the two strains are minimal \[[@pntd.0004988.ref050]\], different duplication rates or other strain characteristics could contribute to different protein expression profiles found between these studies.

10.1371/journal.pntd.0004988.t001

###### *T*. *pallidum* proteins found in previous proteome investigation (McGill *et al*.) \[[@pntd.0004988.ref016]\] but not detected in this study.

![](pntd.0004988.t001){#pntd.0004988.t001g}

  TP number   UniProt Accession Number[^\#^](#t001fn002){ref-type="table-fn"}   Protein Name(s)                                                                                  Molecular Weight (kDa)   COG category code   cDNA/DNA signal ratio Smajs *et al*. \[[@pntd.0004988.ref015]\]
  ----------- ----------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ------------------------ ------------------- -----------------------------------------------------------------
  TP0112      O83150                                                            Aminopeptidase C (PepC)/Bleomycin hydrolase                                                      51                       none                1.0
  TP0139      O83175                                                            Trk family potassium (K+) transporter, NAD+ binding protein                                      25                       P                   0.6
  TP0201      R9UV93                                                            50S ribosomal protein L5                                                                         21                       none                1.8
  TP0216      R9UVA6                                                            Chaperone protein DnaK/Heat shock 70 kDa protein                                                 68                       none                4.5
  TP0239      R9UU25                                                            50S ribosomal protein L10                                                                        20                       none                1.9
  TP0259      O83283                                                            Peptidoglycan binding (LysM domain-bacterial cell wall degradation)                              29                       S                   5.4
  TP0298      R9UW99                                                            ABC superfamily ATP binding cassette transporter, membrane protein/ Membrane lipoprotein TpN38   38                       none                3.3
  TP0349      R9UUA6                                                            Peptidyl-prolyl cis-trans isomerase/ Metallochaperone SlyD                                       18                       O                   2.2
  TP0356      O83375                                                            Putative RNA-binding protein                                                                     12                       none                10.7
  TP0424      R9UWN5                                                            Two-sector ATPase, V(1) subunit E                                                                19                       none                4.7
  TP0435      R9UWP1                                                            Copper resistance lipoprotein NlpE/17 kDa lipoprotein                                            17                       none                5.1
  TP0448      R9UUM3                                                            Uracil phosphoribosyltransferase                                                                 41                       F                   0.3
  TP0453      O67998                                                            Outer membrane protein/30kLp                                                                     32                       none                1.0
  TP0476      R9UWS9                                                            Acetate kinase/Acetokinase                                                                       49                       none                1.3
  TP0505      O83518                                                            Hexokinase                                                                                       48                       none                1.8
  TP0537      R9UTC2                                                            Triosephosphate isomerase                                                                        27                       G                   1.9
  TP0554      O83565                                                            Phosphoglycolate phosphatase                                                                     25                       R                   1.1
  TP0556      R9UWZ4                                                            Aspartate---ammonia ligase/Asparagine synthetase A                                               37                       E                   1.8
  TP0584      R9UTG3                                                            Uncharacterized protein                                                                          54                       none                0.8
  TP0611      O83620                                                            ABC superfamily ATP binding cassette transporter, ABC protein                                    28                       none                1.2
  TP0655      O83661                                                            Spermidine/putrescine ABC superfamily ATP binding cassette transporter, binding protein          40                       E                   0.6
  TP0734      R9UXE0                                                            Purine-nucleoside phosphorylase                                                                  25                       F                   1.6
  TP0769      R9UTV1                                                            Treponemal membrane protein B/ Antigen TmpB                                                      37                       S                   5.2
  TP0821      R9UVI4                                                            Lipoprotein/ Membrane lipoprotein TpN32; 29 kDa protein                                          29                       P                   1.5
  TP0823      O83795                                                            Desulfoferrodoxin (Rbo)                                                                          14                       C                   3.2
  TP0862      O83834                                                            Peptidyl-prolyl cis-trans isomerase                                                              28                       none                5.3
  TP0925      R9UUA1                                                            Nitrogenase (Flavodoxin)                                                                         16                       C                   9.4
  TP0964      O83930                                                            ABC transporter, ATP-binding protein                                                             25                       V                   0.9
  TP0971      R9UX80                                                            Tp34 lipoprotein/ 34kDa membrane antigen                                                         22                       none                12.6
  TP1013      R9UUH7                                                            10 kDa chaperonin/GroES protein/Protein Cpn10                                                    9                        O                   4.6

Legend:

^\#^: UniProt Proteome ID: UP000014259; Clusters of Orthologous Genes (COG)

Detection of possible *T*. *pallidum* heterogeneous sites at the protein level {#sec021}
------------------------------------------------------------------------------

All *T*. *pallidum* protein sequences were screened for possible heterogeneous sites by searching the spectral databases for amino acid sequences containing sites designated with 'X', meaning 'undetermined amino acid site'. Heterogeneous sites were defined as differing amino acids located at the same coordinate 'X' in the same protein sequence. A total of 25 *T*. *pallidum* proteins contained sites designated as 'X', of which four proteins were identified with heterogeneous peptide matches at site 'X' ([Table 2](#pntd.0004988.t002){ref-type="table"}). Amino acid sequence diversity was found within one sample for three proteins, TP0082 (TPC-C), TP0248 (TPC-C) and TP0922 (TPB-B). Protein TP0692 contained two peptides with heterogeneous sites within two samples (TPA-A/TPC-C). This is the first account of sequence heterogeneity at the protein level for these particular proteins. Although the amino acid sequence designation is of high confidence (95%), cautious interpretation of these results is warranted as *de novo* peptide sequencing was not utilized so these analyses could represent falsely identified sites, therefore, further research is advised. *Treponema pallidum* intra-strain nucleotide sequence heterogeneity has been reported previously \[[@pntd.0004988.ref014],[@pntd.0004988.ref066],[@pntd.0004988.ref067]\], including *tprK* \[[@pntd.0004988.ref022],[@pntd.0004988.ref031],[@pntd.0004988.ref032],[@pntd.0004988.ref066],[@pntd.0004988.ref068],[@pntd.0004988.ref069]\] and heterogeneity in four DAL-1 strain genes related to chemotaxis and metabolism \[[@pntd.0004988.ref066]\]. The functional relevance of this observed intra-strain variability in these proteins in currently unknown.

10.1371/journal.pntd.0004988.t002

###### Potential heterogeneous sites identified within peptides of MS detected *T*. *pallidum* proteins.

![](pntd.0004988.t002){#pntd.0004988.t002g}

                                                                                                              Amino acid detected at site \'X\' in peptide sequence                   
  -------- -------- -------------------------------------------------------- ---- --------------------------- ------------------------------------------------------- --- --- --- --- ---
  O88098   TP0082   Formate hydrogenlyase transcriptional activator (FhlA)   66   (R)LYPI[X]{.ul}NAR(K)                                                                   T           D
  O83276   TP0248   Uncharacterized lipoprotein                              15   (R)AYEL[X]{.ul}ER(S)                                                                    T           H
  O83690   TP0692   Protein RecA                                             44   (K)TLRR[X]{.ul}ASR(G)       Y                                                           H   T       P
  O83892   TP0922   Uncharacterized protein                                  33   (R)AL[X]{.ul}GNDPSAAVR(V)                                                           V           A   

Legend:

^\#^: UniProt Proteome ID: UP000014259; Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF/TOF); electrospray ionization LTQ-Orbitrap tandem mass spectrometry (ESI-LTQ-Orbitrap), X = undetermined amino acid site

Bioinformatic characterization of detected *T*. *pallidum* proteins {#sec022}
-------------------------------------------------------------------

Bioinformatic analyses assigned 279 detected proteins to 19 higher Clusters of Orthologous Genes (COG) functional category levels according to their eggNOG assignments. Distributional description of these proteins and their categorical frequencies are depicted in [Fig 2](#pntd.0004988.g002){ref-type="fig"} and extensive descriptions, including COG/NOG codes for all detected proteins, can be found in [S2 Table](#pntd.0004988.s002){ref-type="supplementary-material"}. Of the proteins that were delegated into a clear functional category, the highest representative categories were 'J' (translation, ribosomal structure and biogenesis) (17%) and 'L' (replication, recombination and repair) (12%). High category coverage was found for the categories 'M' (cell wall/membrane/envelope biogenesis) and 'O' (posttranslational modification, protein turnover and chaperones) with 25/28 and 17/21 proteins found, respectively. Forty-five proteins fell under category 'S' or 'R', indicating poor functional characterization. A total of 9 proteins had no UBLAST hit to any eggNOG sequence (category 'no_hit'), of which 5 proteins were ribosomal and 4 were uncharacterized. Many proteins (N = 275) were at least 70% homologous to a protein member not assigned an eggNOG code (category 'none') indicating that the *T*. *pallidum* proteome is very unique compared to other organisms. Six proteins were categorized under multiple COG categories. In almost all of the COG categories, more than half of the predicted proteins were detected, supporting the theory that *T*. *pallidum* has shed its unnecessary genes during its evolution \[[@pntd.0004988.ref013]\].

The *T*. *pallidum* Nichols and SS14 strain genomes differ minimally \[[@pntd.0004988.ref014]\], thus in the case of genetically congruent ORFs we extrapolated recent *T*. *pallidum* strain SS14 hypothetical protein function re-annotations \[[@pntd.0004988.ref028]\] to 22 'uncharacterized/hypothetical' proteins detected in this analysis. In total, 114 proteins remained classified as 'uncharacterized proteins/hypothetical proteins'. This category did not include 17 proteins with ambiguous "putative" membrane protein descriptions. A previous study \[[@pntd.0004988.ref016]\] detected eight of these uncharacterized proteins, meaning that this is the first account of 106 'uncharacterized/hypothetical' proteins at the protein level. This uncharacterized area of the *T*. *pallidum* proteome may contain novel proteins with important roles in pathogenesis and even represent novel biomarker, treatment or vaccination targets.

Predicted cellular localization of detected *T*. *pallidum* proteins {#sec023}
--------------------------------------------------------------------

The global classification of detected proteins according to their cellular localization was achieved by screening online databases such as UniProt and by reviewing relevant literature. The cellular localization of the proteins was predicted for 292/557 proteins; these were largely localized in the cytoplasm (N = 97, 17%), membrane (N = 116, 21%), ribosome (N = 33, 6%) and flagella (N = 19, 3%). A schematic breakdown of the predicted cellular localizations for all detected proteins can be found in [Fig 3](#pntd.0004988.g003){ref-type="fig"}, with comprehensive information for each protein provided in [S2 Table](#pntd.0004988.s002){ref-type="supplementary-material"}.

![Pie diagram depicting the subcellular localization of *T*. *pallidum* detected by MS analysis (N = 557).\
Almost half of the detected proteins (N = 265; 48%) did not have an annotated cellular location. Of the known locations, membrane (N = 116; 21%), cytoplasm (n = 99; 18%), ribosomal (N = 33; 6%) and flagella (N = 19; 3%) were the most represented cellular localizations.](pntd.0004988.g003){#pntd.0004988.g003}

Detected proteins were subjected to additional bioinformatic pipeline analyses in order to identify potential membrane proteins as detailed in the methods section. In short, all potential membrane proteins (N = 131; including proteins annotated as 'hypothetical') were analyzed using five bioinformatic prediction tools: SignalP 4.1 \[[@pntd.0004988.ref054]\], LipoP \[[@pntd.0004988.ref055]\], PSORTb \[[@pntd.0004988.ref056]\], TMHMM \[[@pntd.0004988.ref057]\] and PRED-TMBB \[[@pntd.0004988.ref058]\]. Proteins with unclear subcellular localization predictions using the above bioinformatics pipeline (N = 25) were further analyzed using an additional eight prediction tools including CELLO \[[@pntd.0004988.ref059]\], Philius \[[@pntd.0004988.ref060]\], Phobius \[[@pntd.0004988.ref061]\], Octopus/Spoctopus \[[@pntd.0004988.ref062]\], HMMTOP \[[@pntd.0004988.ref063]\], Tmpred, BOMP \[[@pntd.0004988.ref064]\] and TMBETADISC-RBF \[[@pntd.0004988.ref065]\]. A results summary of this analysis can be found in [Fig 4](#pntd.0004988.g004){ref-type="fig"} and [S4 Table](#pntd.0004988.s004){ref-type="supplementary-material"}.

![Bioinformatics pipeline analysis for potential *T*. *pallidum* membrane proteins.](pntd.0004988.g004){#pntd.0004988.g004}

In total, 116 proteins were designated as 'membrane' localized, with a majority (64%; N = 74) located within the inner membrane. Sixteen proteins (14%) were predicted to be located in the outer membrane (OM) ([Table 3](#pntd.0004988.t003){ref-type="table"}). The OM localization of five detected proteins has been experimentally investigated: (TP0117 (TprC)/ TP0131 (TprD) \[[@pntd.0004988.ref027],[@pntd.0004988.ref037],[@pntd.0004988.ref070]\], TprI (TP0620) \[[@pntd.0004988.ref038]\], TP0126, an OmpW homologue \[[@pntd.0004988.ref071]\] and TP0326, a BamA homologue \[[@pntd.0004988.ref027],[@pntd.0004988.ref072]--[@pntd.0004988.ref074]\].

10.1371/journal.pntd.0004988.t003

###### Predicted *T*. *pallidum* outer membrane proteins detected by MS analysis.

![](pntd.0004988.t003){#pntd.0004988.t003g}

  TP number                                     UniProt Accession Number[^\#^](#t003fn002){ref-type="table-fn"}   Protein Name                                 References
  --------------------------------------------- ----------------------------------------------------------------- -------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  TP0011                                        O83055                                                            Tpr protein B                                Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0117[\*](#t003fn003){ref-type="table-fn"}   O88138                                                            Tpr protein C (TprC)/ Tpr protein D (TprD)   Anand *et al*. 2012 \[[@pntd.0004988.ref037]\]; Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]; Centurion-Lara *et al*. 2013 \[[@pntd.0004988.ref070]\]
  TP0126                                        R9UV28                                                            Uncharacterized protein                      Giacani *et al*., 2015 \[[@pntd.0004988.ref071]\]
  TP0131[\*](#t003fn003){ref-type="table-fn"}   O88138                                                            Tpr protein C (TprC)/ Tpr protein D (TprD)   Anand *et al*. 2012 \[[@pntd.0004988.ref037]\]; Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]; Centurion-Lara *et al*. 2013 \[[@pntd.0004988.ref070]\]
  TP0155                                        O83190                                                            M23B subfamily peptidase                     Cameron *et al*. 2004 \[[@pntd.0004988.ref075]\]; Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0313                                        O83335                                                            Tpr protein E (TprE)                         Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0324                                        R9USU0                                                            Putative outer membrane protein              Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0326                                        O83346                                                            Outer membrane protein                       Cameron *et al*. 2000 \[[@pntd.0004988.ref074]\]; Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]; Desrosiers *et al*. 2011 \[[@pntd.0004988.ref072]\]
  TP0421                                        O83436                                                            Uncharacterized protein                      Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0620                                        R9UV07                                                            Tpr protein I (TprI)                         Giacani *et al*., 2005 \[[@pntd.0004988.ref076]\]; Centurion-Lara *et al*. 2013 \[[@pntd.0004988.ref070]\]; Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]; Anand *et al*. 2015 \[[@pntd.0004988.ref038]\]
  TP0621                                        F7IWA5                                                            Tpr protein J (TprJ)                         Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0855                                        R9UWW7                                                            Putative outer membrane protein              Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0858                                        R9UXR8                                                            Uncharacterized protein                      Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0865                                        R9UU78                                                            Putative outer membrane protein              Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]
  TP0923                                        R9UX30                                                            Putative outer membrane protein              
  TP0969                                        R9UUH1                                                            Putative outer membrane protein              Cox *et al*. 2010 \[[@pntd.0004988.ref027]\]

Legend:

^\#^: UniProt Proteome ID: UP000014259,

\**tprC* and *tprD* alleles are identical at the genomic level in DAL-1 strain \[[@pntd.0004988.ref050]\]

The other 11 predicted OM proteins in this analysis were: TprB (TP0011), M23B subfamily peptidase (TP0155), TprE (TP0313), TprJ (TP0621), TP0421, TP0858, TP0324, TP0855, TP0865, TP0923 and TP0969.

A previous *in silico* prediction analysis of the *T*. *pallidum* genome revealed 46 predicted lipoproteins \[[@pntd.0004988.ref026]\]. Our analysis also detected 25 lipoproteins, 23 with unknown membrane locations and two located within the periplasm (TP0796; TP0171), including the 15 kDa (Tpp15) lipoprotein (TP0171) and 47 kDa membrane antigen (TP0574). In spirochetes, lipoproteins are highly expressed molecules primarily localized in the periplasm anchored to the outer leaflet of the cytoplasmic membrane \[[@pntd.0004988.ref009]\] where they are thought to modulate immune responses from both innate and adaptive immunity \[[@pntd.0004988.ref043],[@pntd.0004988.ref077]\].

There were ambiguities regarding the subcellular localization of 13 proteins after analysis with the additional prediction tools ([S4 Table](#pntd.0004988.s004){ref-type="supplementary-material"}), including TprG (TP0317), TprH (TP0610), ABC superfamily ATP binding cassette transporter (TP0786), flagellar hook length control protein FliK (TP0729) and two TolC-like proteins (TP0967 and TP0968). Of the 49/116 reported membrane proteins that could be designated to a COG category, two categories were most represented: 'P' (inorganic ion transport and metabolism) (N = 9) and 'M' (cell wall/membrane/envelope biogenesis) (N = 6). This agrees with the predicted biological functional location.

Important to note is the fact that most of the protein localization data is based on computational predictions. These types of predictions have an inherent risk of including false positives and also omitting real OM proteins. Further laboratory work is needed to experimentally confirm the cellular locations of these proteins.

Relative *T*. *pallidum* protein abundance as determined by spectral counting {#sec024}
-----------------------------------------------------------------------------

We examined the relative abundance of the proteins detected by calculating the NSAF values \[[@pntd.0004988.ref078]\] for the proteins detected in the biological and technical runs; all values are listed in [S3 Table](#pntd.0004988.s003){ref-type="supplementary-material"} and the log distribution of all detected proteins can be found in [Fig 5A](#pntd.0004988.g005){ref-type="fig"}. This approach is based on the number of observable peptides and normalizes technical variability between samples \[[@pntd.0004988.ref078]\]. A value of '1' represents the mean protein level for all detected proteins. Proteins with an average NSAF value greater than 5.0 were regarded as 'highly abundant'. A summary of the top 50 highest abundant proteins according to the spectral counting averages is provided in [Table 4](#pntd.0004988.t004){ref-type="table"}. High abundant proteins (N = 103) included two proteins related to redox balance, 22 proteins related to translation, two proteins related to chemotaxis and three ABC family transport proteins. Proteins related to motility were found to be high abundant, including flagellar filament proteins (TP0663; TP0792; TP0868; TP0870) and 3 proteins related to flagellar biosynthesis (TP0403; TP0658; TP0718). The fact that proteins related to motility, transport and chemotaxis are highly expressed can be indicative that these processes are essential and highly utilized for cell survival.

![(a) Histogram depicting the distribution of detected *T*. *pallidum* proteins sorted according to their protein abundance amounts (Log expression NSAF values) (b) Scatter Plot of Microarray cDNA/DNA ratio signal *versus* NSAF spectral count average for all MS detected proteins.\
Statistical analysis revealed no correlation between protein abundance and microarray data (Pearson's correlation coefficient r = 0.26). Proteins not detected did not have a significantly lower microarray signal as calculated by a two-sample Wilcoxon rank-sum test (P = 0.5). Red line designates cutoff for 'high abundant' proteins (NSAF value \> 5.0)](pntd.0004988.g005){#pntd.0004988.g005}

10.1371/journal.pntd.0004988.t004

###### Top 50 most abundant *T*. *pallidum* proteins detected by MS analysis.

![](pntd.0004988.t004){#pntd.0004988.t004g}

  TP number                                      UniProt Accession Number[^\#^](#t004fn002){ref-type="table-fn"}   Protein Name                                                                                              Molecular Weight (kDa)   Average NSAF value   cDNA/DNA signal ratio Smajs *et al*. \[[@pntd.0004988.ref015]\]   GO Biological Process                                                                     Cellular location                            COG category
  ---------------------------------------------- ----------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- ------------------------ -------------------- ----------------------------------------------------------------- ----------------------------------------------------------------------------------------- -------------------------------------------- --------------
  TP0214                                         R9UVZ6                                                            Uncharacterized protein                                                                                   7                        19.6                 1.6                                                                                                                                                         Unknown                                      no_hit
  TP0708                                         R9UXB8                                                            Uncharacterized protein                                                                                   18                       15.7                 1.5                                                                                                                                                         Inner membrane                               none
  TP0385                                         O83400                                                            Uncharacterized protein                                                                                   14                       13.6                 1.2                                                                                                                                                         Unknown                                      none
  TP0951                                         R9UVX4                                                            50S ribosomal protein L34                                                                                 6                        13.1                 1.8                                                               Translation                                                                               Ribosome                                     no_hit
  TP0126a[\*](#t004fn003){ref-type="table-fn"}   R9UTR8                                                            Uncharacterized protein                                                                                   23                       13.1                 1.1                                                                                                                                                         Unknown                                      none
  TP0474                                         R9UUP5                                                            Probable transcriptional regulatory protein                                                               26                       13.1                 3.3                                                               Regulation of transcription, DNA-templated                                                Cytoplasm                                    K
  TP0061                                         R9UTJ4                                                            30S ribosomal protein S18                                                                                 12                       12.5                 1.2                                                               Translation                                                                               Ribosome                                     none
  TP0048                                         O83087                                                            Cell shape determination protein CcmA                                                                     15                       12.1                 1.1                                                                                                                                                         Unknown                                      none
  TP0657                                         R9UWD4                                                            Carbon storage regulator homolog                                                                          8                        12.0                 0.9                                                               mRNA catabolic process; regulation of carbohydrate metabolic process                      Unknown                                      none
  TP0409a                                        R9UT20                                                            Preprotein translocase subunit YajC                                                                       14                       11.4                 1.6                                                                                                                                                         Inner membrane                               none
  TP0718                                         R9UXC7                                                            IIISP family Type III (Virulence-related) secretory pathway protein/Flagellar biosynthesis protein FliP   31                       11.2                 0.8                                                               Bacterial-type flagellum organization; protein secretion                                  Flagellum/Inner membrane                     N
  TP0808                                         R9UWS1                                                            Acyl carrier protein                                                                                      9                        10.1                 2.8                                                               Fatty acid biosynthesis; Fatty acid metabolism                                            Cytoplasm                                    none
  TP0558                                         O83569                                                            Nickel/cobalt efflux system                                                                               32                       9.8                  0.9                                                                                                                                                         Inner membrane                               none
  TP0198                                         R9USD7                                                            30S ribosomal protein S17                                                                                 10                       9.8                  1.5                                                               Translation                                                                               Ribosome                                     none
  TP0849                                         R9UU63                                                            50S ribosomal protein L35                                                                                 8                        9.7                  7.1                                                               Translation                                                                               Ribosome                                     no_hit
  TP0490                                         O83503                                                            Uncharacterized protein                                                                                   7                        9.6                  0.7                                                                                                                                                         Unknown                                      no_hit
  TP0649                                         O83655                                                            Hemolysin (TlyC)                                                                                          30                       9.5                  0.6                                                                                                                                                         Inner membrane                               P
  TP0213                                         R9USF3                                                            50S ribosomal protein L17                                                                                 19                       9.4                  2.2                                                               Translation                                                                               Ribosome                                     J
  TP0072                                         O83111                                                            Glutaredoxin-related protein                                                                              10                       9.4                  7.6                                                               Cell redox homeostasis                                                                    Unknown                                      none
  TP0509                                         O83522                                                            Alkyl hydroperoxide reductase (AhpC)/Peroxiredoxin                                                        21                       9.3                  15.5                                                                                                                                                        Unknown                                      O
  TP0919                                         R9UVS2                                                            Thioredoxin                                                                                               11                       9.2                  8.1                                                               Cell redox homeostasis; glycerol ether metabolic process                                  Unknown                                      none
  TP0362                                         R9USW9                                                            50S ribosomal protein L28                                                                                 8                        8.9                  5.4                                                               Translation                                                                               Ribosome                                     none
  TP0368                                         R9UVP4                                                            Uncharacterized protein                                                                                   12                       8.7                  0.8                                                                                                                                                         Inner membrane                               none
  TP0119                                         O83156                                                            Amino acid ABC transporter, permease protein (YaeE)                                                       23                       8.7                  0.7                                                               Transport                                                                                 Inner membrane                               none
  TP0195                                         R9USH3                                                            30S ribosomal protein S3                                                                                  28                       8.5                  1.9                                                               Translation                                                                               Ribosome                                     J
  TP0604                                         R9UUZ6                                                            Ribosome-recycling factor                                                                                 21                       8.4                  1.6                                                               Protein biosynthesis; translation termination                                             Cytoplasm                                    J
  TP0045                                         R9UUU2                                                            Adenosine deaminase                                                                                       35                       8.3                  0.4                                                               Hydrolase activity; metal ion binding; deaminase activity; nucleotide metabolic process   Unknown                                      F
  TP0700                                         R9UV74                                                            Uncharacterized protein                                                                                   14                       8.0                  3.7                                                                                                                                                         Unknown                                      none
  TP0315                                         R9USP4                                                            Uncharacterized protein                                                                                   23                       8.0                  0.9                                                                                                                                                         Unknown                                      none
  TP0922                                         O83892[\*](#t004fn003){ref-type="table-fn"}                       Uncharacterized protein                                                                                   33                       7.8                  1.6                                                                                                                                                         Unknown                                      none
  TP0887                                         R9UVP5                                                            30S ribosomal protein S15                                                                                 10                       7.8                  4.3                                                               Translation                                                                               Ribosome                                     none
  TP0707                                         R9UTN7                                                            Putative membrane protein                                                                                 17                       7.6                  0.6                                                                                                                                                         Inner membrane                               none
  TP0202                                         R9UTZ5                                                            30S ribosomal protein S14 type Z                                                                          7                        7.6                  1.8                                                               Translation                                                                               Ribosome                                     no_hit
  TP0433                                         R9UT05                                                            Acidic repeat protein                                                                                     66                       7.6                  1.4                                                                                                                                                         Unknown                                      none
  TP0663                                         R9UV45                                                            Putative flagellar filament outer layer protein FlaA; Tromp-2                                             27                       7.5                  13.9                                                              Bacterial-type flagellum-dependent cell motility                                          Flagellum                                    none
  TP0076                                         R9UUX9                                                            Sugar ABC superfamily ATP binding cassette transporter, membrane protein                                  30                       7.4                  0.4                                                               Transport                                                                                 Inner membrane                               G
  TP1029                                         R9UY97                                                            Uncharacterized protein                                                                                   25                       7.4                  0.9                                                                                                                                                         Unknown                                      none
  TP0249                                         R9UVD9                                                            Flagellar filament outer layer protein (FlaA1)                                                            39                       7.4                  16.1                                                                                                                                                        Flagellum                                    N
  TP1012                                         O83976                                                            RNA polymerase sigma factor                                                                               35                       7.4                  0.5                                                               DNA-templated transcription; initiation                                                   Polymerase                                   K
  TP0206a                                        R9UU00                                                            50S ribosomal protein L30                                                                                 7                        7.4                  2.0                                                               Translation                                                                               Ribosome                                     no_hit
  TP0194                                         R9UVW4                                                            50S ribosomal protein L22                                                                                 14                       7.3                  1.8                                                               Translation                                                                               Ribosome                                     J
  TP0234                                         R9UU20                                                            50S ribosomal protein L33                                                                                 7                        7.2                  4.2                                                               Translation                                                                               Ribosome                                     no_hit
  TP0007                                         R9URZ2                                                            Uncharacterized protein                                                                                   35                       7.1                  1.8                                                                                                                                                         Unknown                                      none
  TP0412                                         O83427                                                            Uncharacterized protein                                                                                   12                       7.1                  1.2                                                                                                                                                         Unknown                                      S
  TP0792                                         R9UU06                                                            Flagellin/ Flagellar filament 33 kDa core protein; Class B                                                31                       7.0                  13.8                                                              Bacterial-type flagellum-dependent cell motility                                          Flagellum                                    N
  TP0654                                         O83660                                                            Spermidine/putrescine ABC superfamily ATP binding cassette transporter, membrane protein                  30                       6.9                  1.0                                                               Transport                                                                                 Inner membrane                               none
  TP0563                                         O83574                                                            Uncharacterized protein                                                                                   16                       6.9                  0.8                                                                                                                                                         Unknown                                      O
  TP0248                                         O83276[\*](#t004fn003){ref-type="table-fn"}                       Uncharacterized lipoprotein TP_0248                                                                       15                       6.8                  1.5                                                                                                                                                         Lipoprotein- unknown membrane localization   S
  TP0403                                         O83418                                                            Flagellar biosynthesis protein FliJ                                                                       18                       6.8                  0.8                                                               Bacterial-type flagellum-dependent cell motility; chemotaxis                              Flagellum                                    none
  TP0842                                         R9UU24                                                            Methionine aminopeptidase                                                                                 27                       6.8                  0.8                                                               Protein initiator methionine removal                                                      Unknown                                      J

Legend:

^\#^: UniProt Proteome ID: UP000014259; NA: not available; NSAF normalized spectral abundance factor; no_hit: proteins with no UBLAST hit to any eggNOG sequence; none: over 70% of hits to a member that is not assigned an eggNOG code.

\*: the C-terminal 49 amino acids of TP0126a correspond to the N-terminal 49 amino acids of TP0126 due to a genome insertion \[[@pntd.0004988.ref029]\]

In terms of the cellular localizations of high abundant proteins, 18 were membrane localized. Four of these proteins were predicted lipoproteins (TP0248, TP0768, TP0895, TP0789) and two were predicted OM uncharacterized proteins (TP0858, TP0126). Surprisingly, approximately a third of the high-abundant proteins (N = 37) were classified as uncharacterized/hypothetical and seven proteins did not have any significant (70%) match with any other EggNOG sequences indicating these are highly specialized *T*. *pallidum* proteins that may play an important role in unique survival and virulence tactics. The most highly represented COG category of the highly expressed proteins was category 'J' (translation, ribosomal structure & biogenesis). A low correlation was found between previous gel-based studies \[[@pntd.0004988.ref016],[@pntd.0004988.ref017]\] that determined protein abundance based on silver staining and protein abundance as determined in this study. For example, some highly abundant gel-detected proteins were not detected in our analysis, such as the uncharacterized protein TP0259 and the Tp34 lipoprotein (TP0971) \[[@pntd.0004988.ref016],[@pntd.0004988.ref017]\]. We found a low correlation between the average transcriptional rate (cDNA/DNA signal) from a previous transcriptome study \[[@pntd.0004988.ref015]\] and the average NSAF value for each detected protein found in this study (Pearson's correlation coefficient, r = 0.26; P = 0.000). The distribution of these data is depicted in [Fig 5B](#pntd.0004988.g005){ref-type="fig"}. In general, flagellar proteins and proteins related to flagellar biosynthesis such as flagellar filament outer layer protein (TP0249), putative flagellar filament outer layer protein FlaA (TP0663), and flagellar biosynthetic protein FliP (TP0718) were highly expressed in both studies. There were some notable discordances between the data, such as the high gene expression level measured for lipoprotein antigen Tp47 (TP0574), galactose ABC superfamily ATP binding cassette transporter Tpp38 (TP0684) and the 60kDa chaperonin (TP0030), all of which were found in low abundance at the protein level in this study. Moreover, 27 proteins with high gene expression (cDNA/DNA signal ratios greater than 4.0) were not found in this analysis ([Table 1](#pntd.0004988.t001){ref-type="table"}). We theorized that the proteins we failed to detect in our analysis would have a lower mean transcription rate. There was however, no significant cDNA/DNA signal data difference between the detected and undetected proteins as determined by a Two-sample Wilcoxon rank-sum (Mann-Whitney) test (P = 0.5). Other studies have demonstrated low correlations between transcriptome and protein abundance data, as reviewed by Maier *et al*. \[[@pntd.0004988.ref079]\]. Intermediary factors such as translation efficiency and protein half-life play a prominent role in accentuating the lack of a linear association between gene expression and protein abundance.

*T*. *pallidum* proteins confirmed or predicted to be related to virulence {#sec025}
--------------------------------------------------------------------------

Thirty-nine proteins implicated in *T*. *pallidum* virulence \[[@pntd.0004988.ref020]\] were detected, including eight members of the *tpr* gene family and a protein related to a beta-barrel assembly machinery (BAM) complex. Brief descriptions of these proteins are detailed below.

Tpr proteins {#sec026}
------------

Regarding the *tpr* gene family implicated in host-immune evasion \[[@pntd.0004988.ref030]\], 8/12 of these proteins were detected in this analysis, including proteins TprB (TP0011), TprC/D (TP0117/TP0131), TprE (TP0313), TprG (TP0317), TprH (TP0610), TprI (TP0620) and TprJ (TP0621). Proteins TprA (TP0009), TprK (TP0897) and TprL (TP1031) were not detected. There was no unique TprF peptide sequence found in this analysis, although three peptides were uncovered that are homologous for TprC/D, F and I ([Table 5](#pntd.0004988.t005){ref-type="table"}). The ORF origin of these peptides cannot be determined. The *tprC* and *tprD* loci contain two identical coding sequences in the reference Nichols and DAL-1 strain genome \[[@pntd.0004988.ref013],[@pntd.0004988.ref070]\], therefore we included the detection of both TprC and TprD since no distinction could be made between the coding ORF origin of these proteins. Even though *tprK* was previously shown to exhibit the highest level of transcription among tpr family genes \[[@pntd.0004988.ref080]\], the fact that *tprK* displays high sequence variability \[[@pntd.0004988.ref036]\] makes the likelihood of detecting this protein minimal due to rigid MS analytical criteria.

10.1371/journal.pntd.0004988.t005

###### Peptide Sequences of Proteins TprB, C/F/I, E/G/J and H, Detected by MS analysis.

![](pntd.0004988.t005){#pntd.0004988.t005g}

  Protein             Peptide Sequence Identified
  ------------------- ------------------------------------------
  Tpr protein B       NELAAQMR
  Tpr protein B       VKGKGTNSR
  Tpr protein C       APMNALNIDALLRMQWK
  Tpr protein C/F/I   GEARSGVWAQLQLK
  Tpr protein C/F/I   SGVWAQLQLK
  Tpr protein C/F/I   TALLWGVGGR
  Tpr protein E       TNGTQVVNIDVTVPVNVRQSPVR
  Tpr protein E       VEQAVQENIR
  Tpr protein E/G/J   AGISASLIEK
  Tpr protein E/G/J   DKLLWNVGGR
  Tpr protein E/G/J   IPVQDYGWVKPSVTVHASTNRAHLNAPAAGGAVGATYLTK
  Tpr protein E/G/J   TTNTVGVSFPLVMR
  Tpr protein G       KKTDALDAGQQIR
  Tpr protein G       KTDALDAGQQIR
  Tpr protein G       TDALDAGQQIR
  Tpr protein H       AGDAYTHLIDGLEAGMDVR
  Tpr protein H       RVRSVGTWALLFMSSAAGLCAETR
  Tpr protein H       LHTLASTPR
  Tpr protein H       RTLLSPSAAVR
  Tpr protein H       TKVTPGGPVAYAIAQR
  Tpr protein I       FIQMALVK
  Tpr protein I       VATDSGDR
  Tpr protein J       MVGEALIKQQLSR
  Tpr protein J       NNANMQAVGGSLGDTARMVGEALIK
  Tpr protein J       NNNGNPLPSGGSSGHIGLPVVGK
  Tpr protein J       QDLADLVPMMR

BAM-complex {#sec027}
-----------

Outer membrane beta-barrel proteins (OMPs) are commonly involved in cellular process such as small molecule efflux (such as antibiotics) and nutrient acquisition \[[@pntd.0004988.ref081],[@pntd.0004988.ref082]\] in bacteria. The beta-barrel assembly machinery (BAM) complex \[[@pntd.0004988.ref083]\] is thought to facilitate OMP assembly, insertion and folding and in Gram-negative bacteria this complex is typically composed of five proteins: BamA, which is an integral membrane protein and four accessory lipoproteins, BamB-BamE \[[@pntd.0004988.ref084]\]. The insertion and assembly of proteins into the outer membrane is controlled through interactions with periplasmic chaperones (SurA, Skp, and DegP) \[[@pntd.0004988.ref085]\]. Studies \[[@pntd.0004988.ref072],[@pntd.0004988.ref086]\] have demonstrated the presence of a BAM complex in *T*. *pallidum* which is similar to that of *Escherichia coli* \[[@pntd.0004988.ref072]\]. We detected the BamA orthologue (TP0326) \[[@pntd.0004988.ref072],[@pntd.0004988.ref087],[@pntd.0004988.ref086],[@pntd.0004988.ref074]\]. Peptides identified corresponded to the POTRA 2 & 3 domains and a transmembrane domain/ extra-cellular Loop L3 \[[@pntd.0004988.ref072],[@pntd.0004988.ref086]\] ([Table 6](#pntd.0004988.t006){ref-type="table"}).

10.1371/journal.pntd.0004988.t006

###### Peptides Related to BamA orthologue protein (TP0326) identified in MS analysis and corresponding (topological) domain locations.
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  Identified peptide sequence   Sequence location   (Topological) Domain Location[\*](#t006fn001){ref-type="table-fn"}
  ----------------------------- ------------------- --------------------------------------------------------------------
  MKVDQESLR                     141--149            POTRA 2
  VDQESLRR                      143--150            POTRA 2
  AFTESVLK                      197--203            POTRA 3
  KVLSTQEAR                     205--213            POTRA 3
  VEGVAKTVDK                    246--255            POTRA 3
  AGSYGNGLPHPYTSR               514--529            Trans-membrane beta-strand 5/ Extra-cellular Loop L3

\*based on experimental predictions \[[@pntd.0004988.ref072],[@pntd.0004988.ref086]\]

Other detected proteins implicated in *T*. *pallidum* virulence {#sec028}
---------------------------------------------------------------

In our analyses we detected a selection of additional proteins that have been previously implicated in *T*. *pallidum* virulence and pathogenesis, as reported in [Table 7](#pntd.0004988.t007){ref-type="table"}.

10.1371/journal.pntd.0004988.t007

###### Proteins identified in this study that have been previously implicated in *T*. *pallidum* virulence.
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  ORF Number(s)            Reported/predicted functional role   Supporting reference
  ------------------------ ------------------------------------ ---------------------------------------------------
  TP0967, TP0968, TP0969   TolC-like proteins                   \[[@pntd.0004988.ref088],[@pntd.0004988.ref089]\]
  TP0155                   Fibronectin binding protein          \[[@pntd.0004988.ref075]\]
  TP1038                   Bacterioferrin/ TpF1                 \[[@pntd.0004988.ref090]\]
  TP0027, TP0649           Putative hemolysins                  \[[@pntd.0004988.ref091]\]

Exploring the undetected *T*. *pallidum* proteins {#sec029}
-------------------------------------------------

Of the predicted protein coding ORFs, 482/968 proteins were not detected in this study. Most of the undetected proteins are classified as 'uncharacterized proteins/hypothetical proteins' (N = 197), 'conserved hypothetical integral membrane proteins (N = 10), or 'conserved hypothetical protein' (N = 1). The most plausible explanations for not detecting half of the proteome are i) very low protein abundance could evade MS detection, ii) lack of protein expression during *in vivo* expression during some or all stages of infection, iii) small proteins are less viable to detection since they contain fewer peptides and/or these protein sequences lack arginine or lysine tryptic digestion sites or iv) the presence of (partial) sequence heterogeneity that would thwart peptide/database matching. Certain caveats of MS analyses will always preclude the detection of the whole proteome of organisms. A non-exhaustive list of other technical limitations include: i) hydrophobic peptides do not elute from LC columns during the applied gradient, ii) spectral masking of low abundant proteins by the presence of high abundant protein spectra, iii) co-elution and ion suppression that may prevent the ionization or detectability of some peptides by MS and iv) some peptides are unable to ionize sufficiently on the MS platform.

Variable *T*. *pallidum* genomic sequences as modulators of protein expression {#sec030}
------------------------------------------------------------------------------

To address the possibility that the presence of variable sequences may have affected proteome coverage, either by altered gene expression or by precluding MS detection, we searched for known and predicted heterogeneous sequences in the *T*. *pallidum* genome. Within this analysis we looked for sequences containing elements indicative of phase variation (homopolymeric tracts) or antigenic variation through gene conversion (tandem repeats, *tprK* donor sites and quadruplex forming G-rich sequences (G4FS)). Previous investigations have identified and characterized 19 genes with variable sequence elements, of which 9 proteins were detected in this analysis. Aside from the 12 aforementioned Tpr family proteins there are seven additional genes shown to contain variable sequence elements including: *tprK* donor sequences to promote gene conversion (*tp0130; tp0129; tp0128*), homopolymeric G-tracts (poly-G tracts) in promoter regions to alter transcription (TP0126), poly-G tracts in the ORF to induce phase variation (TP0127), or G4FS *cis-acting* DNA elements that form guanine quadruplexes to induce recombination and gene conversion (TP0104; TP0136) \[[@pntd.0004988.ref032],[@pntd.0004988.ref036],[@pntd.0004988.ref067],[@pntd.0004988.ref070],[@pntd.0004988.ref092]\]. Notably, TP0136, a fibronectin binding protein implicated in *T*. *pallidum* virulence not detected in this analysis, harbors two G4FS sequences localized within tandem repeats in the ORF \[[@pntd.0004988.ref093]\]. Surprisingly, the paralogues of TP0136: TP0133, TP0134, TP0462 and TP0463 were also not detected. Among these seven additional variable sequences only an OmpW homologue (TP0126) was detected in our analyses.

We also searched for predicted variable sequences in the *T*. *pallidum* genome. A previous *T*. *pallidum* genomic study predicted the presence of G4FS which may be involved in generation of *tprK* variants in pathogenic treponemes \[[@pntd.0004988.ref032]\]. Similar G4 DNA structures have been implicated in the host immune evasion tactics of *Neisseria gonorrhoeae* where they function as recombination activation elements to regulate gene conversion and the expression of cell surface pilin proteins (PilE) \[[@pntd.0004988.ref094]\]. Giacani *et al*. (2012) identified 46 putative G4FS sequences located in 33 different genes and eight unique intergenic regions (IGRs) of *T*. *pallidum*; 21 of the 33 predicted G4FS-containing ORFs were detected in this analysis. Among the eight putative G4FS residing within unique IGRs, only two of the downstream proteins were detected in this study (TP0104; TP0549). Additionally, we searched for the presence of tandem repeats \[[@pntd.0004988.ref095],[@pntd.0004988.ref096]\] in ORFs and IGRs of genes for which peptides had previously been detected using MS \[[@pntd.0004988.ref016]\] or exhibited high transcript abundance \[[@pntd.0004988.ref015]\]. The presence of highly mutable sites, or contingency loci, such as tandem repeats have been suggested to represent a mechanism for rapid environmental adaptation and virulence within a host \[[@pntd.0004988.ref097]\]. This has been explored in a recent study involving serial *in vivo* passage of *Campylobacter jejuni* in mice that resulted in increased phases in the contingency loci and virulence \[[@pntd.0004988.ref098]\]. This analysis identified three additional genes harboring tandem repeats (*tp0470; tp0424; tp0769*), providing a possible rationale for why these proteins remained undetected in this study. Our study detected 30 proteins out of a total of 60 proteins with known and predicted variable sequences. Remarkably, four proteins discovered in this analysis were only annotated in the original *T*. *pallidum* genome \[[@pntd.0004988.ref013]\], mostly due to the fact that sequences below 150 base pairs were not annotated as protein coding in the resequenced genome \[[@pntd.0004988.ref014]\]. Perhaps there is a need for deeper mining of the *T*. *pallidum* genome and re-evaluation of the definition of protein coding sequences, especially in light of the recent attention brought to classes of endogenous polypeptides called 'SEPs' (sORF-encoded polypeptides). These polypeptides are encoded by short open reading frames (small ORFs or smORFs) (generally \<150 amino acids in length) in bacteria and eukaryotic organisms and are thought to play an important function in biological functions \[[@pntd.0004988.ref099]\] such as cell survival under conditions of glucose toxicity as studied in *E*. *coli* \[[@pntd.0004988.ref100]\]. Interestingly, in *M*. *pneumonia*, 53% of all smORFs are deemed essential to cell survival whilst another 11% affect the fitness of the organism \[[@pntd.0004988.ref101]\], indicating that these may also play a large (unknown) role in *T*. *pallidum* biological function.

In general, proteins in small genomes are more likely to function as proficient "multitaskers" and have been shown to interact with other proteins from a wider range of functions in comparison to their orthologues in larger genomes \[[@pntd.0004988.ref102]\]. It is possible that many *T*. *pallidum* proteins perform multiple biological functions, especially under different environmental conditions. A growing area in proteomics is the concept of 'protein moonlighting', defined as a single protein that displays multiple functions that are not related to multiple RNA splice variants, multiple proteolytic fragments or gene fusions \[[@pntd.0004988.ref103]\]. Many bacterial species employ protein moonlighting and the role of this phenomenon in bacteria virulence has been excellently reviewed by Henderson *et al*. \[[@pntd.0004988.ref104],[@pntd.0004988.ref105]\]. Some bioinformatic approaches have been suggested to approach genome wide annotation of potential moonlighting proteins \[[@pntd.0004988.ref106],[@pntd.0004988.ref107]\]; these may be useful for future *T*. *pallidum* proteome studies.

One of the many intriguing aspects of *T*. *pallidum* is the fact so many proteins lack homology with proteins from other bacteria. This is exemplified by the fact that only 59% (581/968) of the *T*. *pallidum* protein coding genes were allocated into COG or NOG categories. With the demonstrated expression of 114 uncharacterized/ hypothetical *T*. *pallidum* proteins in this study, some even at high abundance, further experimental analysis is needed to elucidate the functions of these proteins such as looking at protein binding partners. Periodic re-evaluations of 'uncharacterized' *T*. *pallidum* proteins are warranted, especially with the rapid sophistication of bioinformatics tools and the growing repertoire of proteins with known predicted functions from other organisms.

We are confident in the quality and extent of the protein coverage of this analysis. For example, we performed analysis on three biological replicates, employed multidimensional peptide separation techniques together with complementary MS analyses in order to improve the dynamic range and coverage of the analyses. Nevertheless, there are a number of limitations related to this study.

Limitations {#sec031}
-----------

Even though our experimental approaches aimed to closely mimic the physiological conditions of human infection, a distinct advantage over the artificial conditions of *in vitro* studies, we cannot exclude the effects of inter-rabbit variability. Different rabbits may exert unique immune pressures, which in turn may influence gene expression. The fact that infected rabbits typically do not transition into the secondary stage of syphilis \[[@pntd.0004988.ref108]\] and there is no tertiary stage in rabbits \[[@pntd.0004988.ref109]\] may suggest that the infectious dynamics of rabbit syphilis may differ from that of humans. Moreover, there may be differential gene expression depending upon the tissue environment \[[@pntd.0004988.ref015]\], therefore the analysis of intradermal rather than intratesticular infections of rabbits, or sampling of human syphilitic lesions (pending ethical consent) could provide interesting insights into differing protein expression profiles. Lastly, technical handling after testicular extraction and treponemal purification may 'stress' the bacteria into a non-characteristic infectious expression state and some proteins may degrade quickly after extraction since individual protein half-life ranges can vary from several seconds to tens of hours \[[@pntd.0004988.ref110]\]. Gentle and prompt sampling and handling of treponemal extract samples may help to alleviate these potential interferences.

Despite purification efforts through Percoll density gradient centrifugation, the high abundant rabbit albumin may have masked the spectra of some lower abundant *T*. *pallidum* proteins. Additional purification or pre-fractionalization steps could be added to facilitate the detection of low abundant proteins, however, there is a risk of inadvertently depleting treponemal proteins through methods such as albumin depletion. Possible experimental method improvements include altering the LC-MS/MS settings to be focused on either small or large proteins and/or using alternative protease and/or multi protease protein digestion \[[@pntd.0004988.ref111]\]. Regarding the use of spectral counting, this method remains a semi-quantitative estimation of protein abundance since proteins are not measured compared to a reference. More absolute and precise protein quantification methods could be used in the future such as isobaric tags for relative and absolute quantification (iTRAQ) or selected reaction monitoring (SRM) as reviewed by Maaß and Becher \[[@pntd.0004988.ref112]\].

Conclusions {#sec032}
-----------

This study makes a number of contributions to the characterization of the *T*. *pallidum* proteome: i) we detected 557 *T*. *pallidum* proteins expressed during *in vivo* experimental rabbit infection using complementary mass spectrometry detection techniques; this is the first account of 499 proteins at the protein level using these methods, ii) protein abundance semi-quantified by spectral counting showed a low correlation with previous gene expression transcriptome data, iii) 116 predicted membrane localized proteins were detected, of which 16 have evidence supporting outer membrane localization and iv) a number of virulence factors were detected, including 8/12 Tpr proteins.

Supporting Information {#sec033}
======================

###### Mass spectrometry data reports for biological (N = 3) and technical runs (N = 2).

(XLSX)

###### 

Click here for additional data file.

###### Extensive descriptions of all unique *T*. *pallidum* proteins identified in this study by mass spectrometry analysis.

(XLSX)

###### 

Click here for additional data file.

###### Peptide identifications per biological (N = 3) and MS run (N = 2) and corresponding calculated spectral counting NSAF values.

(XLSX)

###### 

Click here for additional data file.

###### *T*. *pallidum* membrane protein bioinformatic pipeline prediction analyses.

(XLSX)

###### 

Click here for additional data file.
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